his best bet is

來源: 於 2013-01-13 20:27:55 [博客] [舊帖] [給我悄悄話] 本文已被閱讀：次

ponatinib, or Iclusig, formally known as AP24534 in clinical trials, made by a Boston-based company Ariad Pharmaceuticals, Inc. 

Iclusig was approved by FDA about a month ago, for treatment of AML and Ph+ ALL that can no longer be controlled by Gleevac and chemotherapies.